Phenylketonuria Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 17
SKU : PH2150
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
What is the Projected CAGR value of the Phenylketonuria Treatment Market ?
Phenylketonuria Treatment Market is expected to grow at a CAGR of 9.46% during the forecast period 2024-2031.
Who are the key players in Phenylketonuria Treatment Market ?
Major players are BioMarin, SOM Innovation Biotech SL, Homology Medicines, Inc., Par Pharmaceutical, PTC Therapeutics, and Synlogic, Inc.
Related Reports
pharmaceuticals

Cystinuria Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 September 22
Starting from

$4350

pharmaceuticals

Hematuria Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 September 28
Starting from

$4350

pharmaceuticals

Spinal Stenosis Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 December 19
Starting from

$4350

pharmaceuticals

Porphyria Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 January 19
Starting from

$4350

pharmaceuticals

Presbyopia Treatment Market Size, Share, Industry, Forecast and Demand (2023-2030)

Published: 2023 November 23
Starting from

$4350

pharmaceuticals

Penile Cancer Treatment Market Size, Share, Forecast and Outlook (2023-2030)

Published: 2023 September 26
Starting from

$4350